Contact
Please use this form to send email to PR contact of this press release:
AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma
TO:
Please use this form to send email to PR contact of this press release:
AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma
TO: